Investor Relations
Investor Relations Contact:
LHA
Anne Marie Fields
212-838-3777
afields@lhai.com
or
Bruce Voss
310-691-7100
bvoss@lhai.com

Media Contact
Rooney & Associates
Terry Rooney
212-223-0689
trooney@rooneyco.com
or
Marion Janic
212-223-4017
mjanic@rooneyco.com

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform more »

OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 more »

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy more »

Email Alert Subscription

Step 1 of 3: Select Options

You may automatically receive OPKO Health, Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.

Press Releases
SEC Filings
  
  
  
Stock Information
Send me a stock update at the end of the trading day.
Send me a stock update at the end of the week.
Alert me when the stock changes more than % in one day.
Alert me when the stock crosses the following price thresholds:
Current Stock Price is $4.800
    

Unsubscribe from Investor Relations email alerts.

Our email alerts provide automated opt-out methods as well as complete contact information.